Detailed Programme

Monday 8th November

Breast Educational Workshop: Strategies for targeted axillary dissection–Tips and tricks

09:15–11:15 (AUDITORIUM VII)

Chair: Riccardo Audisio, IT

Co-Chair: Maria Joao Cardoso, PT

09:15

Carbon dye

Speaker: Pedro Gouveia, PT

09:35

Magnetic markers

Speaker: Andreas Karakatsanis, SE

09:55

Intraoperative guided axillary surgery

Speaker: Isabel Teresa Rubio, SP

10:15

Need for standardization of axillary management after neoadjuvant treatment

Speaker: Sabrina Maaskant-Braat, NL

10:35

Discussion

Upper GI Scientific Symposium

09:15–10:45 (AUDITORIUM VI)

Chair: Domenico D’Ugo, IT

Co-chair: Andreas Brandl, PT

09:15

Prehabilitation and ERAS in Oesophageal and Gastric Cancer Surgery

Speaker: Jacopo Weidelmeyer, IT

09:30

Hereditary Diffuse Gastric Cancer–20 years on

Speaker: Fatima Carneiro, PT

09:45

Gastro data

Speaker: Gian Luca Baiocchi, IT

10:00

Frailty

Speaker: William Allum, UK

10:15

Gastric and oesophageal cancer in Portugal

Speaker: PaUlo Costa, PT

Peritoneal Metastasis from Gastric Cancer

10:45–11:15 (AUDITORIUM VI)

10:45

Intraperitoneal chemotherapy for patients with gastric cancer

Speaker: Andreas Brandl, PT

11:00

Cytoreductive Surgery in patients with peritoneal metastasis

Speaker: Beate Rau, DE

Posters in the spotlight - PSM & Interdisciplinary

Monday, 11:15 – 11:45 (10’ break; presentations start at 11:25)

Moderator: Delia Cortes-Guiral

ESSO40-0482 – Comparison between Arm Port and Chest Port for Central Venous Access in Breast Cancer Treatment

Ana Margarida Correia, PT

ESSO40-0348 – Timed Up and Go test and long term survival in older adults after oncologic surgery

Sharon Hendriks, NL

ESSO40-0238 – Early Postoperative Intraperitoneal Chemotherapy (EPIC) following Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Pseudomyxoma Peritonei of appendiceal origin

Xavier Fung, GB

ESSO40-0128 – A proposal for modification of PSOGI classification according to Ki-67 proliferation index in pseudomyxoma peritonei

Alvaro Arjona, ES

ESSO40-0246 – CD39 expressing M2 macrophages are elevated in the peritoneal fluid of patients with metastasis of gastric cancer

Vincent Wolf, DE

ESSO40-0426 – Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for diffuse malignant peritoneal mesothelioma is associated with promising oncological outcomes

Olivia A Sgarbura, FR

Plenary Session: Opening Session and Lifetime Achievement Award

11:45–12:30 (AUDITORIUM VII)

Chair: Domenico D’Ugo, IT

Co-Chair: Joaquim Abreu, PT

11:45

ESSO President and Scientific Chair welcome and opening remarks

Speaker: Domenico D’Ugo, IT

11:52

Local Chair welcome and opening remarks

Speaker: Joaquim Abreu, PT

12:00

Presentation of the Lifetime Achievement Award

Speaker: Domenico D’Ugo, IT

12:05

Enhancing the Future of Surgical Oncology

Speaker: Riccardo Audisio, SE

Interdisciplinary Symposium: Women in Surgery Session and ESSO Medal

12:30–13:30 (AUDITORIUM VII)

Chair: Lynda Wyld, UK

Co-Chair: Olivia Sgarbura, FR

12:30

Increasing leadership and mentoring

Speaker: Isabel T. Rubio, SP

12:50

Gender equity in surgery: How to improve it

Speaker: Olivia Sgarbura, FR

13:10

Presentation of the ESSO Medal

Speaker: Domenico D’Ugo, IT

13:13

ESSO Medal Award Lecture: Evolution in axillary surgery in breast cancer

Speaker: Marjut Leidenius, FI

Breast Debate: Oncoplastic surgery should be used for all patients

14:45–16:15 (AUDITORIUM VII)

Moderator: Marjut Leidenius, FI

14:45

Speaker in favour: Florian Fitzal, AT

15:00

Speaker against: Lynda Wyld, UK

15:15

Discussion & Voting

15:35

ESSO40-0304 – Ratul Quddus, GB
Outcomes from complex oncoplastic breast surgery in UK women over the age of 70.   Analysis of data from the Age Gap cohort study

15:45

ESSO40-0428 – Isabel T. Rubio, ES
AXSANA: A European prospective multicenter cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with NACT

15:55

ESSO40-0551 – Michael Golatta, DE
Imaging of Lumpectomy Surface with Large Field-of-View Confocal Laser Scanning Microscopy ‘Histolog® Scanner’ for Breast Margin Assessment in comparison with Conventional Specimen Radiography

16:05

ESSO40-0229 – Claudia Regis, FR
Functional cerebral MRI evaluation of the integration of breast reconstruction into the body schema

PSM Scientific Symposium: Peritoneal metastasis from colorectal cancer

14:45–16:15 (AUDITORIUM VI)

Chair: Beate Rau, DE

Co-chair: Pompiliu Piso, DE

14:45

CRS and HIPEC in the post PRODIGE-7 era

Speaker: François Quenet, FR

15:05

Proactive approach after PROPHYLOCHIP and COLOPEC

Speaker: Pompiliu Piso, DE

15:25

Ongoing projects in Peritoneal Surface Oncology

Speaker: Santiago Gonzalez-Moreno, SP

15:35

European School of Peritoneal Surface Oncology (ESPSO)

Speaker: Santiago Gonzalez-Moreno, SP

15:45

ESSO40-0441 – Mohammad Alyami, SA
Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for unresectable PM from Gastric Cancer, Outstanding Result From multicenter international cohort study

15:55

ESSO40-0648 – Clarisse Eveno, FR (ESSO40-0245 + ESSO40-0042 merged abstracts)
Ten years of French practice combined with a root cause analysis of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

16:05

ESSO40-0356 – Robin Lurvink, NL
The impact of open or laparoscopic surgery for colorectal cancer on the development of metachronous peritoneal metastases – results from a population-based cohort study

Posters in the spotlight (Breast Cancer)

Monday, 16:15 – 16:45 (10’ break; presentations start at 16:25)

Moderator: Niall OHiggins

ESSO40-0571 – Radiofrequency Tag Localisation for Breast Lesions, A single center experience

Huda Alnumani, GB

ESSO40-0597 – Persistent pain after breast cancer treatment, the underdog that is affecting breast cancer survivors

Bo Strijbos, NL

ESSO40-0257 – The evolution and refinement of magnetic-guided sentinel lymph node detection in breast cancer. A systematic review and meta-analysis

Eirini Pantiora, SE

ESSO40-0267 – Preliminary results of the MUltimodal TArgeted axillary Surgery (MUTAS) study (ClinicalTrials.gov: NCT04039893): tailoring axillary dissection in breast cancer patients with infiltrated lymph nodes

Maria Vernet-Tomas, ES

ESSO40-0471 – Triple evaluation of positive axillary nodes in breast cancer after neoadjuvant chemotherapy

Rita Canotilho Torres, PT

Breast Scientific Symposium: Ongoing controversies

16:45–18:15 (AUDITORIUM VII)

Chair: Isabel T. Rubio, SP

Co-chair: Lynda Wyld, UK

16:45

Local therapy of the primary tumor in stage IV. Anything new?

Speaker: Florian Fitzal, AT

17:00

Contralateral prophylactic mastectomy. Following USA direction in Europe

Speaker: Andreas Karakatsanis, SE

17:15

Genomic assays to help determine neoadjuvant treatment. Is it ready for prime time?

Speaker: Noemia Afonso, PT

17:30

No breast surgery for clinical and radiological complete response after neoadjuvant chemotherapy

Speaker: MK Tasoulis, UK

17:45

ESSO40-0418 – Sherko Kümmel, DE
Pembrolizumab vs placebo + chemotherapy as neoadjuvant treatment, followed by pembrolizumab vs placebo as adjuvant treatment for early triple-negative breast cancer (TNBC): Phase 3 KEYNOTE-522 study

17:55

ESSO40-0237 – Tina Hieken, US
Inflammatory Breast Cancer:  Durable Breast Cancer-Specific Survival in HER2+ Patients with a Pathologic Complete Response to Neoadjuvant Therapy

18:05

ESSO40-0216 – Geoff Fisher, GB
Uncovering clinical gaps in the treatment of early HER2+ve breast cancer: An assessment   of clinical practices

JOINT EDUCATIONAL ESSO WITH ESOI (European Society of Oncology Imaging)
Upper GI Educational Workshop: Gastrointestinal Stromal Tumours – presentation, management and case discussion

16:45–18:15 (AUDITORIUM VI)

Chair: Winan van Houdt, NL

Co-chair: William Allum, UK

16:45

Imaging of gastrointestinal stromal tumours

Speaker: Daniele Regge, IT

17:05

Systemic treatment

Speaker: Giovanni Grignani, IT

17:25

Surgical management

Speaker: William Allum, UK

17:45

TBD

Gerard Van Oortmerssen, NL

17:45

Case-based discussion

Discussants: Daniele Regge, IT; Winan van Houdt, NL; William Allum, UK; Giovanni Grignani, IT;Gerard Van Oortmerssen, NL

PSM Case discussion session

16:45–18:00 (MEETING ROOM)

Chair: Santiago Gonzalez-Moreno, SP

Co-chair: Andreas Brandl, PT

16:45

Pseudomyxoma peritonei

Speaker: Delia Cortes-Guiral, DE

17:10

Colorectal Cancer

Speaker: Olivia Sgarbura, FR

17:35

Gastric Cancer

Speaker: Beate Rau, DE

Tuesday 9th November

Colorectal Educational Workshop: Techniques and selected topics

08:30–10:30 (AUDITORIUM VII)

Moderator 1: Ibrahim Edhemovic, SLO

Moderator 2: Nuno Figueiredo, PT

08:30

TAMIS, TME, TTSS, what have we learned? (video)

Speaker: Antonino spinelli, it

08:50

Robotic TME (video)

Speaker: Amjad Parvaiz, gb

09:10

Splenic flexure mobilisation (video)

Speaker: Felix Aigner, DE

09:30

Hereditary colorectal cancer

Speaker: gabriela moeslein, de

09:50

Colorectal cancer in older patients

Speaker: Isacco Montroni, IT

10:10

Immunotherapy in colorectal cancer

Speaker: Geerard Beets, NL

EYSAC Educational Workshop
Dragons’ Den: Opportunity to Pitch your Trial Proposals to a Panel of Experts

08:30–10:30 (AUDITORIUM VI)

Moderators (experts’ panel): Kjetil Soreide, NO; Laura Lorenzon (IT); Wim Ceelen, BE; Gerard Van Oortmerssen, NL

08:30

Groundbreaking changes in surgical oncology

Speaker: William Allum (UK)

08:45

Oncology Trials vs Surgical Trials

Speaker: Thilo Hackert, DE

09:00

Understanding a multi-disciplinary team perspective about omission of surgery for early stage breast cancer

Speaker: Carmela Caballero, BE

09:15

Short-term outcomes of COLon cancer surgery with full bowel preparation (mechanical bowel preparation and oRal AntiBIotics) and no bowel preparation (COLRABI Multicenter Randomized Controlled Trial)

Speaker: Aleksandra Olkina, RU

09:30

Is TP53 Arg72Pro a risk factor for pancreatic cancer in diabetic patients?

Speaker: Laura Antolino, IT

TP53 is not a prognostic marker – clinical consequences of a generally disregarded fact

Speaker: Tamara Braunschmid, AT

09:45

Proofed Trials Discussion with panel and EYSAC experts

10:20

EYSAC Trial Award

Interdisciplinary Session: Immunotherapy

10:30–11:30 (AUDITORIUM VII)

Moderator: Domenico D’Ugo, IT

10:30

Immunotherapy in solid tumours

Speaker: A. Eggermont, NL

10:55

Immunotherapy in GI cancer

Speaker: Andres Cervantes, SP

11:20

Discussion

Posters in Spotlight - Melanoma, Sarcoma, Head & Neck and Thyroid Cancer

Tuesday, 11:30 – 12:00 (10’ break; presentation start at 11:40)

Moderator: TBD

ESSO40-0381 – The role of perioperative chemotherapy in primary high-grade extremity soft tissue sarcoma: A risk-stratified analysis using PERSARC

Ibtissam Acem, NL

ESSO40-0314 – A nationwide prospective clinical trial on active surveillance in patients with non-intra-abdominal desmoid-type fibromatosis; the Grafiti trial

Anne-Rose Schut, NL

ESSO40-0407 – ‘Cost-effectiveness of the three EMA-approved adjuvant systemic therapies in patients with high-risk melanoma: a model-based economic evaluation’

Evalyn Mulder, NL

ESSO40-0598 – A comparison of the efficacy of Isolated limb perfusion for the treatment of in-transit melanoma in patients previously treated with immunotherapy and in immunotherapy naive patients.

Emma Davies, GB

ESSO40-0323 – MET Targeted Molecular Fluorescence Guided Imaging and Quantitative Spectroscopy for the Detection of Lymph Node Metastases in Papillary Thyroid Cancer

Pascal Jonker, NL

Breast Scientific Symposium: Management of local recurrences

12:00–13:30 (AUDITORIUM VII)

Chair: Joaquim Abreu, PT

Co-Chair: Riccardo Audiosio, SE

12:00

Re lumpectomy

Speaker: MK Tasoulis, UK

12:15

Recurrent SLN

Speaker: Sabrina Maaskant-Braat, NL

12:30

Re irradiation

Speaker: Philip Poortmans, BE

12:45

Patient perspectives on locoregional recurrence of breast cancer

Kathi Apostolidis, GR

13:00

ESSO40-0255 – Annelieke Lemij, NL
Predicting postoperative complications and their impact on quality of life and functional status in older patients with breast cancer

13:10

ESSO40-0321 – Louise Merker, GB
Breast Cancer Management in the over 80’s population: are we being fair?

13:20

ESSO40-0497 – Eirini Pantiora, SE
Electronic Patient Reported Outcome Measures (ePROMs) in Patients With Breast Disease: An Open-label, Randomized Controlled Trial on Patient Reported Experience Measures (PREMs) and Effectivity

UGI Scientific Symposium: State of the Art in Oesophageal and Gastric Cancer

12:00–13:30 (AUDITORIUM VI)

Chair: William Allum, UK

Co-chair: Domenico D’Ugo, IT

12:00

Textbook outcome (TO) of gastric cancer surgery

Speaker: Han-Kwang Yang, KR (virtual presentation)

12:20

Is tumour biology in gastric cancer different between Eastern and Western countries?

Speaker: Fatima Carneiro, PT

12:40

ESSO40-0225 – Sander Ubels, NL
TreatmENT of AnastomotiC LEakage after esophagectomy (TENTACLE - Esophagus) study: efficacy of different initial treatment strategies for anastomotic leakage

12:50

ESSO40-0236 - Stefanie Brunner, DE
The CARDIA Trial

13:00

ESSO40-0264 – Mirte Ketel, NL
Competency assessment tool for Minimally Invasive Esophagectomy: development and preliminary construct validity and reliability results

13:10

ESSO40-0474 – Ben Eyck, NL
Outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal squamous cell carcinoma in East Asia versus Western Europe

13:20

Proffered paper presentation

Colorectal Cancer Scientific Symposium: Locally advanced colorectal cancer

14:45–16:15 (AUDITORIUM VII)

Chair: Geerard Beets, NL

Co-chair: Ana Raimundo, PT

14:45

Neoadjuvant treatment in colonic cancer

Speaker: Andres Cervantes, SP

15:05

Neoadjuvant treatment in rectal cancer

Speaker: Michel Rivoire, FR

15:25

Imaging in advanced colorectal cancer

Speaker: daniele regge, it

15:45

Patterns of locoregional failure in patients treated within the RAPIDO trial/The influence of total neoadjuvant treatment on the development and location of distant metastases in patients with locally advanced rectal in the RAPIDO trial

Speaker: Esmee Dijkstra + Renu Bahadoer

15:55

Proffered Paper

16:05

Feasibility and safety of laparoscopic approach in D3 lymph node dissection for colon cancer surgery. COLD trial: analysis of 116 patients included in main center

Speaker: Aleksandra Olkina, RU

Colorectal Cancer Scientific Symposium: Locally advanced colorectal cancer

14:45–16:15 (AUDITORIUM VII)

Chair: Geerard Beets, NL

Co-chair: Ana Raimundo, PT

14:45

Neoadjuvant treatment in colonic cancer

Speaker: Andres Cervantes, SP

15:05

Neoadjuvant treatment in rectal cancer

Speaker: Michel Rivoire, FR

15:25

Imaging in advanced colorectal cancer

Speaker: daniele regge, it

15:45

Patterns of locoregional failure in patients treated within the RAPIDO trial/The influence of total neoadjuvant treatment on the development and location of distant metastases in patients with locally advanced rectal in the RAPIDO trial

Speaker: Esmee Dijkstra + Renu Bahadoer

15:55

Proffered Paper

16:05

Feasibility and safety of laparoscopic approach in D3 lymph node dissection for colon cancer surgery. COLD trial: analysis of 116 patients included in main center

Speaker: Aleksandra Olkina, RU

Scientific Symposium: Clinical research in surgical oncology: integrating multiple disciplines (session supported by the AntiCancer Fund)

14:45–16:15 (AUDITORIUM VI)

Chair: Serge Evrard, FR

Co-chair: Wim Ceelen, BE

14:45

Clinical research in surgical oncology matters – The funder’s perspective

Speaker: Gauthier Bouche, BE

14:55

Surgeon-led (neo)-adjuvant trial

Speaker: Dr. Winan Van Houdt, Netherlands Cancer Institute, NL

15:15

Methodological aspects of surgical trials

Speaker: tba

15:35

Surgical procedures

Speaker: André Mihaljevic, DE

15:55

Surgical oncology clinical trials infrastructure

Speaker: Wim Ceelen (BE)

Posters in the spotlight - Upper GI Cancer & HPB

Tuesday, 16:15 – 16:45 (10’ break; presentations start at 16:25)
 

Moderators: TBD

ESSO40-0178 – Long-term outcome after portal vein resection during     pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matched analysis

James Russell, GB

ESSO40-0564 – Feasibility of multimdodal prehabilitation to enhance preoperative functional capacity of esophageal cancer patients during concurrent neoadjuvant chemotherapies - a pilot interventional study

Jade St-Pierre, CA

ESSO40-0588 – Patients’ preferences for active surveillance or standard oesophagectomy: a discrete choice experiment

Berend Van Der Wilk, NL

ESSO40-0096 – Transthoracic esophagectomy compared to transhiatal extended gastrectomy for adenocarcinoma of the esophagogastric junction: an international retrospective cohort study

Carlo Alberto De Pasqual, IT

ESSO40-0281 – Global Impact of COVID-19 pandemic on Gastric Cancer Treatment: findings from a global cross-sectional multicentre study (GLEOHUG-GC)

Johnn Henry Herrera Kok, ES

Chair: Dara Lundon, IR

Co-chair: Andreas Brandl, PT

16:45

Translating AI innovations into clinical practice

Speaker: Pearse Keane, UK (virtual presentation)

17:05

Demystifying Radiomics: A blueprint for creating value across the cancer continuum

Speaker: Nickolas Papanikolaou, PT

17:20

Artificial Intelligence and Virtual Reality applications in telehealth

Dara Lundon, IRL

17:40

Artificial Intelligence and Augmented Reality in Breast Cancer Surgery

Speaker: Pedro Gouveia, PT

17:55

Deep learning and generative Adversarial Networks applications in oncologic imaging

Speaker: Maria Elena Laino, IT

HPB Debate: All pancreatic cancer patients should receive neoadjuvant therapy before resection

16:45–18:15 (AUDITORIUM VI)

Moderator: Kjetil Soreide, NO

16:45

Speaker in favour: Marc Besselink, NL

17:05

Speaker against: Thilo Hackert, DE

17:25

Discussion & Voting

17:45

ESSO40-0620 - Ronald M Van Dam, NL
Laparoscopic versus open hemihepatectomy: The ORANGE II PLUS multicenter randomized controlled trial

17:55

ESSO40-0540 – Ulrike Heger, DE
Surgical resection of isolated local recurrence in pancreatic carcinoma

18:05

ESSO40-0424 – Jana Hopstaken, NL
Impact of multicenter diagnostic workup on time-to-diagnosis and time-to-treatment in patients with pancreatic ductal adenocarcinoma: a nationwide analysis

Wednesday 10th November

Scientific Symposium: Pelvic malignancy

08:30–09:30 (AUDITORIUM VII)

Chair: S. Gonzalez-Moreno, SP

Co-Chair: Joaquim Abreu, PT

08:30

PelvEx collaborative group: outcome of surgery for advanced pelvic malignancies

Speaker: Des Winter, IRL

08:47

Management of locally advanced rectal Cancer: Role of IORT

Speaker: Lucio Santos, PT

09:04

Reconstruction challenges after extended pelvic surgery

Speaker: rui barbosa, pt

09:21

Training in advanced pelvic malignancy across Europe and beyond – an EYSAC snapshot analysis

SPEAKER: Andreas Brandl, PT

HPB Scientific Symposium: Surgery of tomorrow

Advances in robotics, imaging and AI towards surgical cancer management. Tumour biology and immunology and its influence on surgical outcomes

08:30–09:30 (AUDITORIUM VI)

Chair: Graeme J. Poston, UK

Co-Chair: tba

08:30

Impact on AI on surgery

Speaker: Marc Besselink, nl

08:50

Genomic signatures of Hepatocellular carcinoma in liver transplant

Speaker: Jose B Pereira-Leal, Lisbon, PT

09:10

Immunoscore in metastatic colorectal cancer

Speaker: kjetil soreide, no

Colorectal Scientific Symposium: Early colorectal cancer

09:30–11:00 (AUDITORIUM VII)

Chair: Des Winter, IRL

Co-Chair: Andreas Brandl, PT

09:30

Endoscopic approaches

Speaker: mario dinis ribeiro, pt

09:50

Transanal local excision

Speaker: antonino spinelli, it

10:10

Organ preservation in rectal cancer

Speaker: Geerard Beets, NL

10:30

ESSO40-0100 – Anders Lyng Ebbehøj, DK
Risk factors for lymph node metastases in T1 colorectal cancer differ according to tumour morphology

10:40

ESSO40-0188 – Petra Custers, NL
Quality of life and functional outcome of rectal cancer patients following a Watch-and-Wait approach

10:50

ESSO40-0106 – Renu Bahadoer, NL
Should watch and wait be offered to rectal cancer patients younger than 50 years after a clinical complete response?

Joint session of the Surgical Oncology Section of the Portuguese Society of Oncology (SOC-SPO) and Brazilian Society of Surgical Oncology (SBCO): Education and Training in Surgical Oncology

09:30–11:00 (AUDITORIUM VI)

Chair: Joaquim Abreu, PT
Co-chair: Alexandre Ferreira, BR

09:30

Surgeons who treat cancer need to specialize?
Os cirurgiões que tratam cancro devem especializar-se?

Speaker: Rodrigo Nascimento Pinheiro

09:45

Surgical Oncology Residency Program in Brazil
Residência de Oncologia Cirúrgica no Brasil

Speaker: Alexandre Ferreira, BR

10:00

Postgraduate Education in Surgical Oncology in Portugal
Ensino Pós-graduado de Oncologia Cirúrgica em Portugal

Speaker: Lucio Santos, PT

10:30

ESSO40-0207 – Beatriz Costeira, PT
Long-term locoregional recurrence after breast cancer surgery

10:40

ESSO40-0478 – Ana Margarida Correia, PT
Hereditary Diffuse Gastric Cancer – Experience of a Portuguese Oncology Center

10:50

ESSO40-0430 - Sara Rodrigues, PT
Surgical Treatment of Esophageal Cancer – The First 100 Cases of a Reference Center in Minimally Invasive Approach

Posters in the spotlight (Colorectal Cancer)

Wednesday, 11:00 – 11:30 (10’ break; presentations start at 11:10)

Chair: TBD

11:30

ESSO40-0476 – KHANS technique can reduce postoperative morbidity in rectal cancer surgery and reduce overall costs for hospitalisation

Speaker: Mohid Malik, GB

11:50

ESSO40-0218 – Different surgical approaches in the treatment of rectal NETs considering the biological and morphological features of the neuroendocrine tumors

Speaker: Mykola Zubaryev, UA

12:10

ESSO40-0140 – Impact of COVID-19 on Colorectal Cancer Patients at Basildon and Southend University Hospitals

Speaker: Abdalla Saad Abdalla Al-Zawi, GB

Interdisciplinary Session: Advances in Surgical Oncology

11:30–13:00 (AUDITORIUM VII)

Chair: G. Beets, NL

Co-chair: Nuno Abecasis, PT

11:30

Advances in oncological imaging

Speaker: daniele regge, it

11:50

The surgical oncologist of the future

Speaker: Isabel Rubio, SP

12:10

Towards minimally invasive cancer surgery

Speaker: Douglas Tyler, USA

12:30

Use of PROMs as an outcome measure

Patient advocate point of view: Robert Greene, UK (ECPC Board member)

12:50

Discussion

Colorectal Cancer Debate: Should a D3 lymphadenectomy be standard in colon cancer?

11:30–13:00 (AUDITORIUM VI)

Chair: Michel Rivoire, FR

Co-chair: Gabriela Moeslein, DE

11:30

Speaker in favour: Felix Aigner, DE

11:45

Speaker against: Des Winter, IRL

12:00

Discussion & Voting

12:10

ESSO40-0615 – Barbara Noiret, FR
Postoperative mortality after cytoreductive surgery alone for peritoneal metastasis of  colorectal origin need centralization in expert centers: a national study of 5,893 patients

12:20

ESSO40-0371 – Michelle Dietz, NL
Survival Outcomes after Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in patients with Synchronous versus Metachronous onset of Peritoneal Metastases of Colorectal Carcinoma

12:30

ESSO40-0399 – Enes Kacmaz, NL
Minimally invasive versus open resection of neuroendocrine tumours of the colon: a nationwide population-based study

12:40

ESSO40-0621 – Michael Kelly, IE
Surgical outcomes in older patients with peritoneal malignancy treated with cytoreductive surgery and hipec: experience the uk and ireland colorectal peritoneal     metastases study group

12:50

ESSO40-0351 – Dirk Van Genechten, BE
Survey of Challenges in Access to Diagnostics and Treatment for Neuroendocrine Tumor  (NET) Patients (SCAN) – application of surgery in treatment of SI NETs

Plenary Session: Congress Highlights and Closing Remarks

13:00–13:30 (AUDITORIUM VI8)

Chair: Domenico D’Ugo, IT

Co-chair: Joaquim Abreu, PT

13:00

Key figures of ESSO 40 (abstracts, registrations)

13:03

Best Proffered Paper Award, Best Poster Award, EBSQ Surgical Oncology exam medal

13:06

Congress Highlights

13:06

Speaker 1: Highlights in HPB/Colorectal cancer surgery

13:11

Speaker 2: Highlights in breast cancer surgery

13:16

Speaker 3: Highlights in gastric cancer

13:21

Closing Remarks